“clinical-trials” Archives

Entry Author Date Location
Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug 06/19/16 Boston
Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle 06/16/16 Boston
Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short 06/14/16 Boston
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another 06/11/16 Boston
In Race to Relief, Amgen Touts New But Incomplete Migraine Data 06/09/16 San Francisco
Pivoting Again, Catabasis Looks to NASH After Cholesterol Drug Flops 06/07/16 Boston
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
Strata Oncology Closes $12M Round, Aims to Increase Tumor Sequencing 06/06/16 Detroit Ann Arbor
Ocular’s Shares Fall After Eye Treatment Fails Latest Test 06/06/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Two Years After Paying $680M, BioMarin Shelves Duchenne Drug 05/31/16 San Francisco
Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug 05/31/16 New York
Celator Parlays Leukemia Drug Data into $1.5B Buyout From Jazz Pharma 05/31/16 New York
FDA Commish Califf to Big Data Crowd: Flood Of New Treatments Coming 05/26/16 National
Minerva’s Shares Soar on Early Data for Schizophrenia Drug 05/26/16 Boston
After Failed Trial, Forum CEO Dunsire Leaves, Company’s Fate Unclear 05/25/16 Boston
Sarepta Saga Drags On as FDA Delays Decision on Duchenne Drug 05/25/16 Boston
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
Tour of Texas: Ride-Hailing, CPRIT, Deep Space, Dean Kamen, START 05/23/16 Texas
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Spark Adds To Early But Promising Data For Hemophilia Gene Therapy 05/19/16 National
CPRIT Marks Midpoint in Texas Agency’s 10-Year Cancer-Fighting Mandate 05/18/16 Texas
Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound 05/16/16 San Francisco
Pressured by a Lender, Bind Files for Bankruptcy 05/02/16 Boston
Texas Roundup: Rapamycin, SparkCognition, MolecularMatch, Rackspace 04/27/16 Texas
Led by Ex-Suros Execs, Nico is Out To Change Brain Surgery 04/27/16 Indiana
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote 04/25/16 Boston
Houston’s MolecularMatch Expands Cancer Patient Treatment Service 04/25/16 Texas
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More 04/22/16 San Francisco
With BioMarin Data, Gene Therapy Finally Shows Impact on Hemophilia A 04/20/16 San Francisco
Page 3 of 19 « previous page · next page »